Literature DB >> 11846898

Outcomes after aneurysm rupture during endovascular coil embolization.

R P Tummala1, R M Chu, M T Madison, M Myers, D Tubman, E S Nussbaum.   

Abstract

OBJECTIVE: Intracranial aneurysm rupture during placement of Guglielmi detachable coils has been reported, but the management and consequences of this event have not been extensively described. We present our experience with this feared complication and report possible neuroradiological and neurosurgical interventions to improve outcomes.
METHODS: We retrospectively reviewed the records for 701 patients with 734 intracranial aneurysms that were treated with endovascular coiling, during a 6-year period, in the metropolitan Minneapolis-St. Paul (Minnesota) area. This analysis revealed 10 cases of perforation during coiling. The management and outcomes were recorded, and the pertinent literature was reviewed.
RESULTS: All 10 cases involved previously ruptured aneurysms. This complication occurred sporadically and was not observed in the first 100 cases. Perforation occurred during microcatheterization of the aneurysm in two cases and during coil deposition in eight cases. Seven of the perforated aneurysms were located in the anterior circulation and three in the posterior circulation. Six of the 10 patients made good or fair recoveries; all three patients with posterior circulation lesions died immediately after rehemorrhage. Elevated intracranial pressure (ICP) was noted for all five patients with intraventricular catheters in place. Bilateral pupil dilation and profound hemodynamic changes were noted for eight patients. Coiling was rapidly completed, and total or nearly total occlusion was achieved in all cases. Emergency ventriculostomy was performed to rapidly reduce increased ICP for two patients, both of whom made good recoveries. Hemodynamic and angiographic factors after perforation, such as prolonged systemic hypertension, persistent dye extravasation after deployment of the first Guglielmi detachable coil, and persistent prolongation of contrast dye transit time (suggesting ongoing ICP elevation), were correlated with poor outcomes.
CONCLUSION: Previously ruptured aneurysms seem to be more susceptible to endovascular treatment-related perforation than are unruptured lesions. Worse prognoses are associated with iatrogenic rupture during coiling of posterior circulation lesions, compared with those in the anterior circulation. When perforation is recognized, the definitive treatment seems to be reversal of anticoagulation therapy and completion of Guglielmi detachable coil embolization. Immediate neurosurgical intervention is limited in these cases and focuses on decreasing ICP via emergency ventriculostomy. However, these measures may be life-saving, and neurosurgical assistance must be readily available during treatment of these cases.

Entities:  

Mesh:

Year:  2001        PMID: 11846898     DOI: 10.1097/00006123-200111000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

1.  Short- and intermediate-term angiographic and clinical outcomes of patients with various grades of coil protrusions following embolization of intracranial aneurysms.

Authors:  M Abdihalim; S H Kim; A Maud; M F K Suri; N Tariq; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

2.  Anatomical and clinical outcomes after endovascular treatment for unruptured cerebral aneurysms. A single-center experience.

Authors:  B J Kwon; M H Han; C W Oh; K H Kim; K H Chang
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

3.  Periprocedural morbidity and mortality by endovascular treatment of cerebral aneurysms with GDC: a retrospective 12-year experience of a single center.

Authors:  G B Bradac; M Bergui; G Stura; M Fontanella; D Daniele; L Gozzoli; M Berardino; A Ducati
Journal:  Neurosurg Rev       Date:  2007-01-11       Impact factor: 3.042

4.  Requirements for emergent neurosurgical procedures among patients undergoing neuroendovascular procedures in contemporary practice.

Authors:  R Khatri; M Ansar; F Sultan; S A Chaudhry; A A Khan; G J Rodriguez; R P Tummala; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-24       Impact factor: 3.825

5.  Force characterization of intracranial endovascular embolization: coil type, microcatheter placement, and insertion rate.

Authors:  Jonathan B Lamano; Grace G Bushnell; Hongyu Chen; Avanti Badrinathan; Najib E El Tecle; Bernard R Bendok; Matthew R Glucksberg
Journal:  Neurosurgery       Date:  2014-12       Impact factor: 4.654

6.  Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms.

Authors:  Hae-Kwan Park; Michael Horowitz; Charles Jungreis; Julie Genevro; Christopher Koebbe; Elad Levy; Amin Kassam
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

7.  Effect of metal artifact reduction software on image quality of C-arm cone-beam computed tomography during intracranial aneurysm treatment.

Authors:  Yukiko Enomoto; Keita Yamauchi; Takahiko Asano; Katharina Otani; Toru Iwama
Journal:  Interv Neuroradiol       Date:  2018-02-21       Impact factor: 1.610

8.  Bioactive-Tissue-Derived Nanocomposite Hydrogel for Permanent Arterial Embolization and Enhanced Vascular Healing.

Authors:  Jingjie Hu; Izzet Altun; Zefu Zhang; Hassan Albadawi; Marcela A Salomao; Joseph L Mayer; L P Madhubhani P Hemachandra; Suliman Rehman; Rahmi Oklu
Journal:  Adv Mater       Date:  2020-06-23       Impact factor: 30.849

9.  Intraprocedural aneurysmal rupture during coil embolization of brain aneurysms: role of balloon-assisted coiling.

Authors:  A Santillan; Y P Gobin; E D Greenberg; L Z Leng; H A Riina; P E Stieg; A Patsalides
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

10.  Procedure-related haemorrhage in embolisation of intracranial aneurysms with Guglielmi detachable coils.

Authors:  B J Kwon; M H Han; C W Oh; K H Kim; K H Chang
Journal:  Neuroradiology       Date:  2003-07-08       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.